Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Correction: Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity

Clin Cancer Res (2022) 28 (10): 2197.

https://doi.org/10.1158/1078-0432.CCR-22-1109

Published: 13 May 2022

View articletitled, Correction: Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity

Journal Articles

Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity

Clin Cancer Res (2019) 25 (20): 6180–6194.

https://doi.org/10.1158/1078-0432.CCR-18-4134

Published: 01 October 2019

View articletitled, Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity

Includes: Supplementary data

Journal Articles

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Clin Cancer Res (2019) 25 (15): 4663–4673.

https://doi.org/10.1158/1078-0432.CCR-18-4142

Published: 01 August 2019

View articletitled, Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Includes: Supplementary data

Journal Articles

Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes

Deborah B. Doroshow, Miguel F. Sanmamed, Katherine Hastings, Katerina Politi, David L. Rimm, Lieping Chen, Ignacio Melero, Kurt A. Schalper, Roy S. Herbst

Clin Cancer Res (2019) 25 (15): 4592–4602.

https://doi.org/10.1158/1078-0432.CCR-18-1538

Published: 01 August 2019

View articletitled, Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes

Journal Articles

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non–Small Cell Lung Cancer

Franz Villarroel-Espindola, Xiaoqing Yu, Ila Datar, Nikita Mani, Miguel Sanmamed, Vamsidhar Velcheti, Konstantinos Syrigos, Maria Toki, Hongyu Zhao, Lieping Chen, Roy S. Herbst, Kurt A. Schalper

Clin Cancer Res (2018) 24 (7): 1562–1573.

https://doi.org/10.1158/1078-0432.CCR-17-2542

Published: 02 April 2018

View articletitled, Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non–Small Cell Lung Cancer

Includes: Supplementary data

Journal Articles

PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors

Harriet M. Kluger, Christopher R. Zito, Gabriela Turcu, Marina K. Baine, Hongyi Zhang, Adebowale Adeniran, Mario Sznol, David L. Rimm, Yuval Kluger, Lieping Chen, Justine V. Cohen, Lucia B. Jilaveanu

Clin Cancer Res (2017) 23 (15): 4270–4279.

https://doi.org/10.1158/1078-0432.CCR-16-3146

Published: 01 August 2017

View articletitled, PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors

Includes: Supplementary data

Journal Articles

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Kurt A. Schalper, Daniel Carvajal-Hausdorf, Joseph McLaughlin, Mehmet Altan, Vamsidhar Velcheti, Patricia Gaule, Miguel F. Sanmamed, Lieping Chen, Roy S. Herbst, David L. Rimm

Clin Cancer Res (2017) 23 (2): 370–378.

https://doi.org/10.1158/1078-0432.CCR-16-0150

Published: 15 January 2017

View articletitled, Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Includes: Supplementary data

Journal Articles

Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites

Harriet M. Kluger, Christopher R. Zito, Meaghan L. Barr, Marina K. Baine, Veronica L.S. Chiang, Mario Sznol, David L. Rimm, Lieping Chen, Lucia B. Jilaveanu

Clin Cancer Res (2015) 21 (13): 3052–3060.

https://doi.org/10.1158/1078-0432.CCR-14-3073

Published: 30 June 2015

View articletitled, Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites

Includes: Supplementary data

Journal Articles

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

Janis M. Taube, Alison Klein, Julie R. Brahmer, Haiying Xu, Xiaoyu Pan, Jung H. Kim, Lieping Chen, Drew M. Pardoll, Suzanne L. Topalian, Robert A. Anders

Clin Cancer Res (2014) 20 (19): 5064–5074.

https://doi.org/10.1158/1078-0432.CCR-13-3271

Published: 30 September 2014

View articletitled, Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

Includes: Supplementary data

Journal Articles

CD137 as a Biomarker for Tumor-Reactive T Cells: Finding Gold in the Desert

Yuwen Zhu, Lieping Chen

Clin Cancer Res (2014) 20 (1): 3–5.

https://doi.org/10.1158/1078-0432.CCR-13-2573

Published: 05 January 2014

View articletitled, CD137 as a Biomarker for Tumor-Reactive T Cells: Finding Gold in the Desert

Includes: Supplementary data

Journal Articles

Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer—Response

Mario Sznol, Lieping Chen

Clin Cancer Res (2013) 19 (19): 5542.

https://doi.org/10.1158/1078-0432.CCR-13-2234

Published: 01 October 2013

View articletitled, Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer—Response

Journal Articles

Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer

Mario Sznol, Lieping Chen

Clin Cancer Res (2013) 19 (5): 1021–1034.

https://doi.org/10.1158/1078-0432.CCR-12-2063

Published: 03 March 2013

View articletitled, Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer

Journal Articles

Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

Evan J. Lipson, William H. Sharfman, Charles G. Drake, Ira Wollner, Janis M. Taube, Robert A. Anders, Haiying Xu, Sheng Yao, Alice Pons, Lieping Chen, Drew M. Pardoll, Julie R. Brahmer, Suzanne L. Topalian

Clin Cancer Res (2013) 19 (2): 462–468.

https://doi.org/10.1158/1078-0432.CCR-12-2625

Published: 16 January 2013

View articletitled, Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

Journal Articles

Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

Rezaul Karim, Ekaterina S. Jordanova, Sytse J. Piersma, Gemma G. Kenter, Lieping Chen, Judith M. Boer, Cornelis J. M. Melief, Sjoerd H. van der Burg

Clin Cancer Res (2009) 15 (20): 6341–6347.

https://doi.org/10.1158/1078-0432.CCR-09-1652

Published: 14 October 2009

View articletitled, Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

Journal Articles

Palettes of Vaccines and Immunostimulatory Monoclonal Antibodies for Combination

Ignacio Melero, Ivan Martinez-Forero, Juan Dubrot, Natalia Suarez, Asis Palazón, Lieping Chen

Clin Cancer Res (2009) 15 (5): 1507–1509.

https://doi.org/10.1158/1078-0432.CCR-08-2931

Published: 27 February 2009

View articletitled, Palettes of Vaccines and Immunostimulatory Monoclonal Antibodies for Combination

Includes: Supplementary data

Journal Articles

Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage

Taishi Yamashita, Hideto Tamura, Chikako Satoh, Eiji Shinya, Hidemi Takahashi, Lieping Chen, Asaka Kondo, Takashi Tsuji, Kazuo Dan, Kiyoyuki Ogata

Clin Cancer Res (2009) 15 (3): 770–777.

https://doi.org/10.1158/1078-0432.CCR-08-0501

Published: 02 February 2009

View articletitled, Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage

Includes: Supplementary data

Journal Articles

Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications in De novo Acute Myeloid Leukemia

Hideto Tamura, Kazuo Dan, Koji Tamada, Kyoko Nakamura, Yumiko Shioi, Hideya Hyodo, Sheng-Dian Wang, Haidong Dong, Lieping Chen, Kiyoyuki Ogata

Clin Cancer Res (2005) 11 (16): 5708–5717.

https://doi.org/10.1158/1078-0432.CCR-04-2672

Published: 22 August 2005

View articletitled, Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications in De novo Acute Myeloid Leukemia

Journal Articles

Interleukin 4 Receptor-directed Cytotoxin Therapy for Human Head and Neck Squamous Cell Carcinoma in Animal Models

Scott E. Strome, Koji Kawakami, Danielle Alejandro, Stephen Voss, Jan L. Kasperbauer, Diva Salomao, Lieping Chen, Richard A. Maki, Raj K. Puri

Clin Cancer Res (2002) 8 (1): 281–286.

Published: 01 January 2002

View articletitled, Interleukin 4 Receptor-directed Cytotoxin Therapy for Human Head and Neck Squamous Cell Carcinoma in Animal Models

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Correction: Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity

Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non–Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non–Small Cell Lung Cancer

PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

CD137 as a Biomarker for Tumor-Reactive T Cells: Finding Gold in the Desert

Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer—Response

Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer

Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

Palettes of Vaccines and Immunostimulatory Monoclonal Antibodies for Combination

Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage

Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications in De novo Acute Myeloid Leukemia

Interleukin 4 Receptor-directed Cytotoxin Therapy for Human Head and Neck Squamous Cell Carcinoma in Animal Models

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only